These Are the Only 3 Stocks That Cathie Wood Bought Last Week

Group 1: Market Overview - The three major market indexes have declined for four consecutive weeks, indicating a challenging environment for most investors [1] - Cathie Wood, founder and CEO of Ark Invest, has historically capitalized on market pullbacks but was notably quiet during this recent downturn [1] Group 2: Ark Invest's Recent Purchases - Ark Invest added to only three existing positions last week, specifically in Figma, Arcturus Therapeutics Holdings, and 10x Genomics [2] - The decision to maintain a light investment approach during a market correction is unusual for Wood, prompting interest in her selection of these three companies [2] Group 3: Figma Analysis - Figma's stock has experienced a significant decline of 83% from its peak last summer, following a previous increase from its original $33 offering price [3] - Despite the stock's decline, Figma's revenue growth accelerated, achieving a year-over-year increase of 40% in the last quarter, up from 38% in the previous quarter [5] - Figma's net dollar-retention rate stands at 136%, indicating that returning customers are spending 36% more than the previous year, marking its best performance in two years [6] - Analysts project a slowdown in revenue growth to 30% this year and 20% next year, highlighting concerns over margin pressure and profitability [6] Group 4: Arcturus Therapeutics - Ark Invest made its first stock purchase of the week in Arcturus Therapeutics on Wednesday, subsequently increasing its stake in the company over the final three trading days [7]